This review explores the therapeutic challenges of sexually transmitted infections (STI) in
Europe, which include increasing antimicrobial resistance and limited progress in drug …

Background To treat Neisseria gonorrhoeae infection, the Centers for Disease Control and
Prevention recommends a single oral dose of cefixime as an alternative to injectable …

Gonococcal infection caused by the Gram-negative bacteria Neisseria gonorrhoeae is one
of the most common sexually transmitted infections (STIs) worldwide. The public health …

Therapeutic options for Neisseria gonorrhoeae are limited due to emerging global
resistance. New agents and treatment options to treat patients with susceptible and multi …

The tracing and treatment of sex partners of patients is an essential component of sexually
transmitted infection (STI) management. The regular implementation of this concept dates …

Challenges in Managing Gonorrhea and New Advances in Prevention - Infectious Disease
Clinics Skip to Main Content Advertisement Infectious Disease Clinics Log in Register Log in …

Neisseria gonorrhoeae is one of the most common bacterial sexually transmitted infections.
The emergence of antimicrobial-resistant N. gonorrhoeae is an urgent public health threat …

Abstract Purpose of Review Antimicrobial resistance in sexually transmitted infections (STIs)
has become an urgent global public health threat, raising the specter of untreatable …

It was in the 1800s when the first public publications about the infection and treatment of
gonorrhoea were released. However, the first prevention programmes were only published …

Background Antimicrobial resistance (AMR) is a major threat to global health. By 2050, it is
forecast that AMR will cause 10 million deaths and cost 100 trillion USD annually. Point-of …